RYBOX Mutual Fund

NAV$72.73
Showing 10 of 75 holdings(as of Mar 31, 2026)Top 10 Weight: 36.65%
#TickerNameWeightSharesMkt ValueShare ChgSectorIndustry
1ABBVAbbvie Inc7.39%45,923$9.99M••••••••••••••••••••••
2AMGNAmgen Inc.5.23%20,093$7.07M••••••••••••••••••••••
3GILDGilead Sciences Inc4.96%48,042$6.70M••••••••••••••••••••••
4VRTXNvaesrtex Pharmaceuticals Inc4.01%12,119$5.41M••••••••••••••••••••••
5REGNRegeneron Pharmaceuticals, Inc.3.56%6,224$4.81M••••••••••••••••••••••
6ALNYAlnylam Pharmace2.60%10,632$3.52M••••••••••••••••••••••
7INSMInsmed Inc2.45%20,277$3.32M••••••••••••••••••••••
8BGNEBeigene, Ltd. (adr)2.29%10,395$3.09M••••••••••••••••••••••
9NTRANatera Inc2.09%14,145$2.83M••••••••••••••••••••••
10UTHRUnited Therapeutics Corp2.07%4,711$2.79M••••••••••••••••••••••
Want to see all 75 holdings?View All HoldingsPRO

Top Holdings Themes

PharmaceuticalsBiotechnologyMedical DevicesImmunologyOncologyLife Sciences ToolsBiotechnology ToolsDigital HealthCardiology

RYBOX Mutual Fund Top Holdings

RYBOX holdings top 10 positions. The top 10 holdings account for 36.6% of the fund, led by Abbvie Inc at 7.4%, Amgen Inc. at 5.2%, Gilead Sciences Inc at 5.0%.

RYBOX portfolio concentration is moderate, with the top 10 representing 36.6% of total assets. The largest sector exposure is Health Care at 95.5%.

RYBOX sector allocation provides a detailed breakdown. RYBOX overlap tool shows how holdings compare to other funds in your portfolio.